Biocept Inc. buy stratec
Start price
26.03.19
/
50%
€300.36
Target price
04.11.21
€811.80
Performance (%)
-65.44%
End price
05.11.21
€103.80
Summary
This prediction ended on 05.11.21 with a price of €103.80. The BUY prediction by stratec for Biocept Inc. performed very badly with a performance of -65.44%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biocept Inc. | - | - | - | - |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,67 % | 45,80 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 14,64 % | 78,69 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,74 % | 45,87 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 9,34 % | 58,52 % |
Comments by stratec for this prediction
In the thread Biocept Inc. diskutieren
stratec stimmt dem Sentiment von 'Buy' zu
Biocept’s Target Selector is a liquid biopsy platform which, in addition to providing actionable data based on circulating tumor DNA (ctDNA) analysis, incorporates circulating tumor cell (NYSE:CTC) analysis which differentiates the company in an increasingly ‘crowded’ liquid biopsy space.”
In the thread Trading Biocept Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten